直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • 生命科学
    • Transportation and Logistics
  • 经验

意见及咨询

About

通过法律意见及咨询评估您的知识产权资产

我们每年提供数百条法律意见,从针对具体专利的单一意见,到提供关于复杂专利组合或诉讼的长期、持续咨询服务。我们为客户解决专利有效性、可执行性、滥用、回避设计、许可潜力、知识产权合同构建和执行、以及出口管制等问题。我们定期与客户的法律、业务和技术人员合作,确认从创意产生到专利组合开始盈利整个过程中的潜在风险和收益。

除交易咨询服务外,我们还长期向客户提供诉讼前策略建议。我们拥有丰富的诉讼经验,能够直接洞察诉讼对手可能提出的各种论据。凭借诉讼和知识产权交易的双重经验,我们能够帮助客户在诉讼前或诉讼中有利解决纠纷。

Everyone in this practice

经验

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer.

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia.

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases.

More

专业见解

Federal Circuit IP Blog

Federal Circuit Reverses Eligibility of Software Claims Where Technical Improvements Were Not Reflected in Claims

April 15, 2026

Federal Circuit IP Blog

Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim

April 15, 2026

Webinar

When Machines Invent: Patenting Innovations in the Age of AI

July 15, 2025

Webinar

Books

Biosimilars Litigation and Client Counseling

June 17, 2024

Seminar

Mobility Innovation: Business & Patent Strategies for Driving Success

May 22, 2024

Tel Aviv

Webinar

IP Agreements: Structuring Indemnification and Limitation of Liability Provisions to Allocate Infringement Risk

January 11, 2024

Webinar

More

新闻

Award/Ranking

10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List

October 5, 2023

Commentary

Eligibility Bill Gives Attys Relief, Even With 'Squishy' Terms

June 28, 2023

Announcement

Aaron Capron Named a 2023 Top Intellectual Property Lawyer

May 17, 2023

Commentary

How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success

December 16, 2020

Charles T. Collins-Chase

Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar

March 6, 2017

James R. Barney

Best Practice Series: Women’s Initiatives

March 17, 2015

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP